Immunic Inc. buy Wedbush
Start price
27.07.23
/
50%
€2.08
Target price
27.07.24
€4.53
Performance (%)
-35.74%
End price
28.07.24
€1.33
Summary
This prediction ended on 28.07.24 with a price of €1.33. The BUY prediction by Wedbush for Immunic Inc. performed very badly with a performance of -35.74%. Wedbush has a follow-up prediction for Immunic Inc. where he still thinks Immunic Inc. is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by Wedbush for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Wedbush gewählte maximale Laufzeit wurde überschritten